In order to reduce attrition due to metabolism mediated toxicity and to improve safety of drug candidates, we developed two in vitro cell based assays by combining an activating system human CYP3A4 with target cells HepG2 cells in the first method we incubated microsomes containing cDNA expressed CYP3A4 together with HepG2 cells; in the second approach HepG2 cells were transiently transfected with CYP3A4 <a href=http://sviagras.cyou>sample of viagra</a> Melissa EuykkyXJyBnk 6 20 2022
